Susquehanna Fundamental Investments, LLC Bio N Tech Se Transaction History
Susquehanna Fundamental Investments, LLC
- $6.8 Billion
- Q4 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 123,657 shares of BNTX stock, worth $14.1 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
123,657Holding current value
$14.1 Million% of portfolio
0.21%Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$937 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$502 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$490 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$216 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$206 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.7B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...